Impact on Students Sample Clauses

Impact on Students assessment via protection;
Sample 1Sample 2
AutoNDA by SimpleDocs
Impact on Students. Generates excitement and enthusiasm for learning. Provides services and special assistance to students through exemplary advising, counseling or mentoring.
Sample 1
Impact on Students. What is the impact of IM’s curriculum on student mathematics achievement? A. How does level of implementation relate with student mathematics achievement, across all relevant student demographic groups? 4. System Conditions. What are the school/system conditions (e.g., leadership, PL, support resources, other) that are commonly associated with increased implementation? And with increased student attitudes toward equity and math? A. Which school/system conditions most contribute to increased implementation and improved teaching practice? (e.g. leadership, equity professional learning, resources, coaching, collaborative planning, vertical alignment, district attrition, etc.) B. How do these conditions interact with PL to improve implementation? EXHIBIT “B” SCHEDULE OF DATA Category of Data Elements Check if used by your system Application Technology Meta Data IP Addresses of users, Use of cookies etc. Other application technology meta data-Please specify: Application Use Statistics Meta data on user interaction with application Assessment Standardized test scores Observation data Other assessment data-Please specify: Attendance Student school (daily) attendance data Student class attendance data Communications Online communications that are captured (emails, blog entries) X Conduct Conduct or behavioral data X via observation Demographics Date of Birth Place of Birth Gender X Ethnicity or race X Category of Data Elements Check if used by your system Language information (native, preferred or primary language spoken by student) Other demographic information-Please specify: Enrollment Student school enrollment X Student grade level X Homeroom Guidance counselor Specific curriculum programs X Year of graduation Other enrollment information-Please specify: Parent/Guardian Contact Information Address Email Phone Parent/Guardian ID Parent ID number (created to link parents to students) Parent/Guardian Name First and/or Last Schedule Student scheduled courses Teacher names X Category of Data Elements Check if used by your system Special Indicator English language learner information X Low income status X Medical alerts /health data Student disability information X Specialized education services (IEP or 504) Living situations (homeless/xxxxxx care) Other indicator information-Please specify: Category of Data Elements Check if used by your system Student Contact Information Address Email Phone Student Identifiers Local (School district) ID number State ID number Vend...
Sample 1

Related to Impact on Students

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Dependencies HP’s ability to deliver services will depend on Customer’s reasonable and timely cooperation and the accuracy and completeness of any information from Customer needed to deliver the services.

  • Regulatory Activities Beginning on the Effective Date and to the extent UGNX remains the Lead Development Party with respect to a particular territory, subject to and in accordance with the terms and conditions of this Agreement and the requirements of Applicable Laws, UGNX, shall: (a) use Commercially Reasonable Efforts to file (or have filed) all Regulatory Filings with respect to the Licensed Products in the Field in order to obtain Marketing Approvals in each country in the Territory and the European Territory (or to obtain the European Centralized Approval in the European Core Territory) and in order to obtain Pricing and/or Reimbursement Approvals in the Profit Share Territory; (b) respond in a timely fashion to requests for data and information from Regulatory Authorities with respect to the Licensed Products in the Field in the Territory and the European Territory; and (c) meet with officials of the Regulatory Authorities at such times as may be requested by such Regulatory Authorities with respect to the Core Development Activities (“Regulatory Activities”), provided that KHK will have primary responsibility for obtaining, and UGNX shall provide all assistance reasonably requested by KHK, in relation to Pricing and/or Reimbursement Approvals for the Licensed Products in the Field in the European Territory. For the avoidance of doubt, UGNX will be responsible for obtaining, and KHK will provide all assistance reasonably requested by UGNX, in relation to Pricing and/or Reimbursement Approvals, if any, for the Licensed Products in the Field in the Profit Share Territory as part of the UGNX Core Development Activities, it being understood that the costs incurred by UGNX in connection with such activities will be shared equally (50/50). All such Regulatory Activities will be conducted in a manner consistent with the Core Development Plan and coordinated by the JSC in accordance with Article 3. Without limiting the applicability of the foregoing and the remainder of this Article 5, UGNX shall interface with the applicable Regulatory Authority(ies) and, through the JDC, shall keep KHK reasonably informed of all material events and developments occurring in the course of the Regulatory Activities, including scheduled UGNX regulatory strategy discussions and meetings with Regulatory Authorities in the Territory and the European Territory relating to the Licensed Products in the Field.

  • Trials The Ship shall run the following test and trials:

  • AGREEMENTS WITH EMPLOYEES AND SUBCONTRACTORS Grantee shall have written, binding agreements with its employees and subcontractors that include provisions sufficient to give effect to and enable Grantee’s compliance with Grantee’s obligations under this Article VI, Intellectual Property.

  • MANAGEMENT OF EVALUATION OUTCOMES 11.1 The evaluation of the Employee’s performance will form the basis for rewarding outstanding performance or correcting unacceptable performance.

  • Program Evaluation The School District and the College will develop a plan for the evaluation of the Dual Credit program to be completed each year. The evaluation will include, but is not limited to, disaggregated attendance and retention rates, GPA of high-school-credit-only courses and college courses, satisfactory progress in college courses, state assessment results, SAT/ACT, as applicable, TSIA readiness by grade level, and adequate progress toward the college-readiness of the students in the program. The School District commits to collecting longitudinal data as specified by the College, and making data and performance outcomes available to the College upon request. HB 1638 and SACSCOC require the collection of data points to be longitudinally captured by the School District, in collaboration with the College, will include, at minimum: student enrollment, GPA, retention, persistence, completion, transfer and scholarships. School District will provide parent contact and demographic information to the College upon request for targeted marketing of degree completion or workforce development information to parents of Students. School District agrees to obtain valid FERPA releases drafted to support the supply of such data if deemed required by counsel to either School District or the College. The College conducts and reports regular and ongoing evaluations of the Dual Credit program effectiveness and uses the results for continuous improvement.

  • STAGE The aggrieved may within twenty-one (21) calendar days after an occurrence, or in the case of disciplinary action within twenty-one (21) calendar days after same has been brought to the attention of the reduce the grievance to writing and accompanied by representatives of the Grievance Committee, take the matter up with the Fire Chief. The Fire Chief shall, within seven (7) calendar days, arrange a meeting place and time to discuss and attempt to settle the grievance. The Corporation will be represented at this stage of the grievance procedure by the Fire Chief and the Director of Human Resources. Grievancesthat are not settled within seven (7)calendar days of the meeting may be referred to Stage provided that not more than seven (7) calendar days have elapsed since the meeting at Stage STAGE2 The aggrieved shall reconsider the grievance and the Fire Chief's response at Stage and decide within five (5) calendar days whether to proceed with the grievance. If the aggrieved wishes to proceed, the Assistant City Manager of Emergency and Corporate Services, the Fire Chief, and the Director of Human Resources will meet with the aggrieved accompanied by representatives of the Grievance Committee within seven (7) calendar days of notification by the aggrieved Failing settlement at this stage, Stage of the grievance procedure may be invoked provided that no more than seven (7) calendar days have elapsed since the hearing at Stage STAGE The aggrieved accompanied by representatives of the Grievance Committee, may then take the written grievance to a committee of Council members. In the case of discharge, the grievance shall be heard by the entire Council. Failing settlement at this stage within fourteen (14) calendar days, then the grievance may be referredto Arbitration, as provided under the "Fire Protectionand Prevention Act Part as amended, provided that not more than thirty

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Student Evaluations Student evaluations shall be completed by the end of the 12th week of the Fall semester.

Time is Money Join Law Insider Premium to draft better contracts faster.